Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Fireman

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
The Journal of Infectious Diseases|January 23, 2023
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION NetworkMark W Tenforde, Zachary A Weber, Malini B DeSilva, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2023
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023Ruth Link-Gelles, Zachary A Weber, Sarah E Reese, et al.
JAMA Network Open|September 26, 2022
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United StatesStephanie J Schrag, Jennifer R Verani, Brian E Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report|August 17, 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023Ruth Link-Gelles, Allison Avrich Ciesla, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report|May 25, 2023
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023Ruth Link-Gelles, Zachary A Weber, Sarah E Reese, et al.
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
Lancet Regional Health. Americas|June 19, 2023
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort studyKatherine Adams, John J Riddles, Elizabeth A K Rowley, et al.
BMJ (Clinical Research Ed.)|October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control studyJill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
JAMA Network Open|June 25, 2025
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in AdultsRuth Link-Gelles, Elizabeth A K Rowley, Stephanie A Irving, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
The Journal of Infectious Diseases|January 23, 2023
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION NetworkMark W Tenforde, Zachary A Weber, Malini B DeSilva, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2023
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023Ruth Link-Gelles, Zachary A Weber, Sarah E Reese, et al.
JAMA Network Open|September 26, 2022
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United StatesStephanie J Schrag, Jennifer R Verani, Brian E Dixon, et al.
MMWR. Morbidity and Mortality Weekly Report|August 17, 2023
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023Ruth Link-Gelles, Allison Avrich Ciesla, Elizabeth A K Rowley, et al.
MMWR. Morbidity and Mortality Weekly Report|May 25, 2023
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023Ruth Link-Gelles, Zachary A Weber, Sarah E Reese, et al.
MMWR. Morbidity and Mortality Weekly Report|March 28, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024Ruth Link-Gelles, Elizabeth A K Rowley, Malini B DeSilva, et al.
Lancet Regional Health. Americas|June 19, 2023
Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021-February 2022, VISION Network: a retrospective cohort studyKatherine Adams, John J Riddles, Elizabeth A K Rowley, et al.
BMJ (Clinical Research Ed.)|October 3, 2022
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control studyJill M Ferdinands, Suchitra Rao, Brian E Dixon, et al.
JAMA Network Open|June 25, 2025
Estimated 2023-2024 COVID-19 Vaccine Effectiveness in AdultsRuth Link-Gelles, Elizabeth A K Rowley, Stephanie A Irving, et al.
MMWR. Morbidity and Mortality Weekly Report|December 29, 2022
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022Mark W Tenforde, Zachary A Weber, Karthik Natarajan, et al.
Pageof 21